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Abstract
Diabetes is a chronic illness that affects many people, and it’s thought that
environmental exposure to certain compounds may increase its proliferation. In this
study, we examine the dietary effects of 2-aminoanthracene (2AA), a polycyclic aromatic
hydrocarbon (PAH), in rats, specifically as it relates to oxidative stress. Oxidative stress
refers to the imbalance of reactive oxygen species (ROS) and antioxidants in living
systems; it has been shown to contribute to type-1 diabetes. To accomplish the study
objectives rats were divided into three dietary treatment groups, control (0 mg/kg-2AA),
low dose (50 mg/kg-2AA) and high dose (100 mg/kg-2AA). Rats were fed 2AA for three
months, and then euthanized using carbon dioxide. Various tissues including the liver and
were flash-frozen in liquid nitrogen. To determine 2AA effects in the liver, a portion of
the liver was homogenized in phosphate buffered saline solution. The supernatant was
analyzed for serum albumin, aspartate aminotransferase (AST), IgA protein, and
antioxidants. Furthermore, genes such as Pdx1, Sod1, Gpx1, Prdx6, Ncf2, Duox1 and
Ptgs2 typically used to measure cellular oxidative stress were quantified. The expressions
of these genes in the liver show the upregulation of Sod1 and Prdx6, and downregulation
of Ptgs2 in treated groups. AST activity was marginally increased in treated groups
while the albumin concentration was elevated in the 50 mg/kg group and reduced in the
100 mg/kg-2AA animals. IgA levels were slightly elevated while antioxidant levels were
reduced in treated groups. Taken together, these results show that ingestion of 2AA may
produce hepatic oxidative stress.
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Background and Objective
Polycyclic aromatic hydrocarbons (PAHs) are a class of organic compounds
produced during the incomplete combustion of hydrocarbons. They can also be formed in
high pressure reactions involving hydrocarbons. People are exposed to PAHs everyday
through many sources such as natural sources (forest fires, volcanos, etc.), cigarette
smoke, vehicle exhaust [Cherg, Wetering, Talsma, Crommelin, & Hennink 1996; Lewitas
1997], and diet. In nonsmokers up to 70% of PAH exposure occurring outside of the
workplace is associated with the diet [Skupinska, Misiewicz, & Kasprzycka-Guttman
2004]. This project will focus of on diet as the point of exposure.
PAHs are known to be carcinogenic. One especially toxic class of PAHs is
anthracenes which are PAHs with the chemical formula C14H10. Anthracenes are
classified as group of top concern by the United States Agency for Toxic Substances and
Disease Registry (ASTDR) due to their toxicity to humans which is by comparison
greater than that of other PAHs. Research has shown 2-aminoanthracene (2AA) to affect
genes involved with carbohydrate and lipid metabolism, as well as inflammation and
immune responses [Wilson, Buckeridge, Yau, Howerth, & Gato 2017]. These effects
have led to symptoms of diabetes in rats.
Just like other PAHs 2AA is mildly carcinogenic. According to previous research
exposure to mild carcinogens can cause oxidative stress [Kakehashi, Wei, Fukushima, &
Wanibuchi 2013], and oxidative stress has been shown to be a factor that may contribute
to type-1 diabetes [Mays, Hunter, Wilson, & Gato 2017]. Oxidative stress is a
phenomenon that occurs when the balance of reactive oxygen species (ROS) to
antioxidants in the body is disturbed. Reactive oxygen and nitrogen species are constantly
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being produced through processes such as cellular respiration. These reactive species are
harmful to the body. They can cause inflammation and damage to the cells. Over time
this can lead to cancerous growth in the cells. Enzymatic antioxidants are needed to break
down the reactive species.
In this project we examine the livers of rats that have been exposed to a diet
containing 2AA. We hypothesized that rats exposed to 2AA for 12 weeks will
demonstrate oxidative stress in their liver cells. This study’s aim was to provide us with
information about the associated risk of type-1 diabetes from exposure to 2AA. In
addition to the damage and inflammation we expected to observe from oxidative stress
we also expected to see inhibition of carbohydrate and lipid metabolism [Wilson et al.
2017]. This information is useful because it provides information about the risk humans
assume from consuming 2AA which can be present in food products. The effects of 2AA
on the liver was measured through analysis of serum isolated from liver samples for
albumin levels, aspartate aminotransferase (AST) activity, IgA protein levels and
antioxidant levels. Furthermore, analysis of specific genes related to oxidative stress was
also carried out. The genes that were quantified in the study included Pdx1, Sod1, Gpx1,
Prdx6, Ncf2, Duox1 and Ptgs2.
Materials and Methods
Animal Study
The rats used in this project were Male Sprague Dawley obtained from Taconic
Bioscience Inc. (Hudson, NY). 2AA was purchased from Sigma Aldrich (St. Louis, MO).
The diet used for this project was The Global Rodent Diet 2020. This formula was
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obtained from Harlan Laboratories Inc. (Madison, WI). 2AA was sent to Harlan
Laboratories and incorporated into some of the diet (all portions besides control).
During the feeding portion of the experiment the rats were housed at the Georgia
Southern University Animal Facility. The rats were fed three different dose regimens 0
mg/kg (control), 50 mg/kg (low dose-LD), and 100 mg/kg (high dose-HD). The rats were
fed the diet for 12 weeks and were then sacrificed using carbon dioxide. The kidneys and
livers of the animals were harvested and measured, and a blood sample was collected.
Discomfort of the Sprague Dawley rats was minimized through treatment methods
outlined in the Institute for Laboratory Research (ILAR) Guide for Care and Use of
Laboratory Animals. All measures and protocols were approved by Institutional Animal
Care and Use Committee (IACUC) prior to beginning the experiment.
Homogenization of Hepatic Tissues
In order to evaluate 2AA effects directly on the liver, 20-30 mg of each hepatic
tissue from each sample was homogenized in 1X PBS (Fisher Scientific, Hampton NH,
Cat#: BP399). Samples were then centrifuged at 4˚C for 15 minutes. The supernatant was
aliquoted and saved in -80˚C freezer until analysis.
Quantitative Determination of Serum Albumin
The concentration of serum albumin in the homogenized liver samples was
determined using the Albumin Reagent Set (Pointe Scientific Inc., Canton, MI, Cat#:
A7502-1L). In this experimentation bromocresol green dye was bound to albumin, and
the absorbance was measured at 630 nm using a UV-Vis spectrometer in accordance with
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the manufactures guidelines. A standard curve was created using Bovine serum albumin
(BSA) to quantify the data collected.
Quantitative Determination of Aspartate Aminotransferase (AST)
Aspartate aminotransferase (AST) activity was measured using the AST (SGOT)
Liquid Reagent Set (Pointe Scientific Inc., Canton, MI, Cat#: A7561-450). This assay
functions by the principle that AST catalyzes and transfers the amino group from Laspartate to α-Ketoglutarate to yield oxalacetate and L-glutamate. In a subsequent
reaction the oxalacetate as NADH is oxidized to form NAD+. As this reaction progresses
the rate of decrease of absorbance measured at 340 nm is directly proportional to the AST
activity. To measure the absorbance accurately lactate dehydrogenase (LDH) must be
added to prevent endogenous pyruvate, which is typically found in serum, from
interfering with the absorbance reading. The experiment was carried out as specified in
the manufacturers guidelines. The following equation was provided by the manufacturer
to calculate AST activity from change in absorbance per minute:
AST (IU/L) = ΔAbs./min × 1768
IgA Quantitative Analysis via ELISA
Using the Mouse IgA Ready-Set-Go! ® (Affymetrix eBioscience, Santa Clara,
CA, Cat#: 88-50450) assay kit IgA protein levels in serum were quantified for each of the
treatment groups using enzyme-linked immunosorbent assay (ELISA). The reaction was
set up in a 96 well microplate, and the absorbance of the plate was measured at 450 nm
using a microplate reader. The experiment was carried out according to the manufactures
guidelines. A standard curve was created from mouse IgA provided with the kit. This
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standard curve was then used to calculate the IgA concentrations for samples from our
study.
Total RNA Isolation
Total RNA was isolated from liver samples using the RNeasy Mini by QIAGEN
Total RNA Isolation Kit (QIAGEN N.V., Hilden, Germany, Cat#: 74104). The
experiment was carried out using the guidelines stated in the protocol. Quality of the
RNA was determined using gel electrophoresis. RNA Sample Loading Buffer (Sigma
Aldrich, Saint Louis, MO, Cat#: R4268) was used for this process. The loading buffer
was mixed at a ratio of 1 volume of sample to 2-5 volumes of RNA Sample Loading
Buffer before being run in a gel. Excess isolated RNA was stored in a -80℃ freezer for
further analysis.
Analysis of Selected Genes
Gene Expression was carried out using quantitative real time polymerase chain
reaction (qRT-PCR) for the oxidative stress specific genes Pdx1, Sod1, Gpx1, Prdx6,
Ncf2, Duox1 and Ptgs2. FASTA mRNA sequences of the genes were generated from the
National Center for the Biotechnology Information (NCBI). Using PrimerQuest by
Integrated DNA Technologies (IDT) (Coralville, IA) forward and reverse primers for
each of the mRNA sequences was obtained. The primers used are listed in Table 1.
cDNA for use in RT-qPCR was synthesized using iScript™ Reverse Transcription
Supermix for RT-qPCR (Bio-Rad, Hercules, CA, Cat#: 1708840). cDNA was diluted
with 10 mM Tris-HCl buffer (pH 8), 01 mM EDTA prior to use in the qPCR system in
accordance with the manufactures guidelines.
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Acession #

Forward

Reverse

PDX-1

U35632

CTGCCTTTCCCATGGATGAA

CTTGATGTGTCTCTCGGTCAAG

SOD1

KR710602

GCAGGTCCTCACTTTAATCCTC

CTTCCAGCGTTTCCTGTCTT

GPX1

KR709800

CATCAGGAGAACGCCAAGAA

TGTCAGGCTCGATGTCAATG

PRDX6

KY383188

CCTCTGAAGGCTCCTGTTTC

AGTAAGGCGCGGGAATTT

PKC

KF705541

GTGCGGTCCTTGTCTTACTT

CCCATCCTCCTTGTCCATAATC

NCF2

KR709852

CTCCGGCTGGAACAAACTAA

CTGGTTGGGTAGCCTCATAAC

DUOX1

GBYX01074484

TCATTCGCCACGCTTTCT

CCTTCGATAAGTAGCCAGTTCC

PTGS2

KR709390

GCGGGAACACAACAGAGTAT

GGACAGCCCTTCACGTTATT

Table 1. Forward and reverse nucleotide sequences used as primers for each gene.
Quantification of Total Antioxidant Capacity
Quantification of total antioxidants present in serum was determined using the
Cayman Chemical Antioxidant Assay Kit (Ann Arbor, MI, Item#: 709001). This assay
relies on antioxidants in the serum samples to inhibit the oxidation of 2,2’-Azino-di-[3ethylbenzthiazoline sulphonate] (ABTS®) to ABTS®*+ by metmyoglobin. The
suppression of ATBS®*+ production can be measured by the by reading the absorbance at
405 or 750 nm. In this experiment absorbance was measured at 405 nm. The absorbance
at either 405 or 750 nm is inversely related to the proposed concentration of antioxidants
in the sample. A standard curve was generated using Trolox, a water-soluble tocopherol
analogue. The concentration of antioxidants is quantified as millimolar (mM) Trolox
equivalents. The reaction setup was prepared in a 96 well microplate, and the absorbance
of standards and samples was measure by a microplate reader. The reaction was set up in
accordance with manufacturers guidelines.
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Results
Quantitative Determination of Serum Albumin
A standard curve of absorbance vs. concentration of bovine serum albumin (BSA)
was generated. This standard curve showed a strong linear relationship demonstrated by
an r-squared value of 0.9837. The linear equation generated from this linear relationship
was found to be y = 0.8414x – 0.0146. This relationship is summarized in Figure 1. This
generated equation was used to calculate concentrations of serum albumin in the rat
samples.

Figure 1. Standard curve of absorbance vs. concentration for bovine serum albumin
(BSA).

Through the analysis of serum albumin levels in rats using the BSA standard
curve it was found that animals in the low dose treatment group experienced a slight
increase in serum albumin levels as compared to control animals; 0.9230 and 0.7933 g/dL
respectively. Whereas animals in the high concentration group experienced a decrease in
serum albumin levels. Serum albumin concentration in high dose animals was found to be
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an average of 0.6037 g/dL. Each groups data is summarized in Figure 2. The standard
error of each mean measurement is displayed in Figure 2.

Figure 2. Mean albumin concentration from serum of rats in control (0 mg/kg-2AA), low
dose (50 mg/kg-2AA), and high dose (100 mg/kg-2AA) treatment groups.
Quantitative Determination of Aspartate Aminotransferase (AST)
AST activity was measured and found to be slightly elevated in rats that had been
fed 2AA. Looking at specific numeric values AST activity was measured to be an
average 106.28 IU/L for the control group, 137.31 IU/L for the low dose group, and
130.54 IU/L for the high dose group. While AST activity was elevated in both treated
groups it was slightly higher in the low dose group. These results are summarized in
Figure 3. The standard error for this measurements is also visualized in Figure 3.
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Figure 3. Mean AST activity levels from serum of rats in control (0 mg/kg-2AA), low
dose (0 mg/kg-2AA), and high dose (100 mg/kg-2AA) treatment groups.

IgA Quantitative Analysis via ELISA
A standard curve of absorbance of standard mouse IgA at 450 nm vs.
concentration of standard mouse IgA was created. This curve showed strong linearity
with a generated linear equation of y = 0.0044x + 0.0839. This equation was used to
calculate the concentration of IgA in our rat serum samples. The linear relation found
from the standard mouse IgA is summarized in Figure 4.
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Figure 4. Standard curve of absorbance vs. concentration of mouse IgA.

Using the generated standard curve concentrations of IgA in the serum samples
the concentrations of IgA were calculated in ng/mL for each treatment group. The
concentration for that of the low dose group was statistically insignificant from the
control while the concentration of the high dose treatment group showed slightly elevated
levels, though this elevation is also relatively statistically insignificant. The average
concentrations of the low dose and high dose groups were 136.22 and 148.55 ng/mL
respectively. The average concentration of IgA in the control treatment group was 133.41
ng/mL. These findings are summarized in Figure 5.
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Figure 5. Mean IgA levels from livers of rats for control (0 mg/kg-2AA), low dose (50
mg/kg-2AA), and high dose 2AA (100 mg/kg-2AA) treatment groups.

Analysis of Selected Genes
At the conclusion of PCR analysis relative quantities of each gene were determine
along with their standard deviation in the real-time PCR measurements. The expression
of these genes showed upregulation od Sod1 and Prdx6, and downregulation of Ptgs2.
The results of this experiment are represented graphically in Figure 6.
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Figure 6. Relative gene expression for select genes (Duox1, Gpx1, Ncf2, Pdx-1, Prdx6,
Ptgs2, and Sod1) in RNA extracted from the livers of rats. Rats were either in the control
(0 mg/kg-2AA), low dose (50 mg/kg-2AA), or high dose (100 mg/kg-2AA) treatment
groups.

Quantification of Total Antioxidant Capacity
A standard curve was generated using Trolox where an inverse relationship
between absorbance and concentration was shown. The standard curve showed a strong
linear relationship and generated a linear equation of y = -1.5663x + 0.8309. This
equation was then used to quantify the concentration of antioxidant in the serum samples
from each of the animal treatment groups. The linear relationship from the standard curve
is visualized in Figure 7.
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Figure 7. Standard curve generated from Trolox when absorbance was measured at 405
nm.

The antioxidant concentration as millimolar Trolox equivalents was determined
and it was found that antioxidant concentration was decreased in treated animals. Low
dose treated animals showed lower antioxidant concentrations than high dose treated
animals, but both groups demonstrated a decrease in antioxidant concentration as
compared to the control group. The average concentrations for each group were found to
be 0.2268 mM equivalents for the control group, 0.1673 mM for the low dose group, and
0.1877 mM for the high dose group. This information is displayed on Figure 8 along with
the standard error for each measured group.
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Figure 8. Inhhibition of ABTS oxidation by antioxidants for control (0 mg/kg-2AA), low
dose (50 mg/kg-2AA), or high dose (100 mg/kg-2AA) treatment groups.

Discussion
The primary objective of this study was to demonstrate oxidative stress in the
livers of rats exposed to 2AA. Two very important markers when looking to identify
oxidative stress are serum albumin levels and antioxidant capacity in body fluids
[Marrocco, Altieri, & Peluso 2017]. Albumin is a protein that has shown antioxidant
properties. Through the reversible process of albumins oxidation of its cysteine residues
albumin is able to act as an antioxidant and can be used as a general oxidative biomarker
for oxidative stress based diseases [Marrocco et al. 2017]. In this study albumin levels
were shown to be in higher concentration in the low dose treatment group and lower in
the high dose treatment group as compared to the control (Figure 2). The decrease in
albumin in the high dose treated group is a change we would expect to see due to
albumins antioxidant properties, but the higher concentration of albumin in the low dose
treatment groups makes this evidence relatively inconclusive. In future study total protein
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concentrations could be measured to demonstrate the relative albumin level compared to
the total protein concentration. As expected from previous research antioxidant capacity
in serum was lower in both treated groups as compared to the control (Figure 8). In the
antioxidant assay kit used in this study it is assumed that the antioxidant activity is
equivalent to the reducing capacity [Marrocco et al. 2017]. Therefore, lower antioxidant
capacity demonstrates an inability of the organism to break down ROS, and correlates to
an imbalance in the ROS to antioxidants ratio known as oxidative stress.
Another marker that can be used to demonstrate oxidative stress is gene
expression of genes that code for antioxidants. The genes measured in this study are
involved with the coding of proteins and enzymes that break down ROS. The genes
analyzed in this study included Pdx1, Sod1, Gpx1, Prdx6, Ncf2, Duox1 and Ptgs2. The
genes that showed noticeable increase in expression where Sod1 and Prdx6 (Figure 6).
Sod1 is a gene that codes for the production of the enzyme copper-zinc superoxide
dismutase, commonly called SOD1. SOD1 is a member of the SOD class of antioxidant
enzymes responsible for detoxifying superoxide anions by converting them to hydrogen
peroxide. Expression of Sod1 can be induced by redox-active metals and superoxides
[Messner, Murray, & Kowdley 2012]. Mice with Sod1 knockout experienced increased
liver tumors likely do increased ROS [Elchuri et al. 2005]. In our study Sod1 was
upregulated in treated individuals likely do to an immune response to cellular damage
from ROS. Prdx6 was also shown to be significantly upregulated in both of our treated
groups. Prdx6 is a gene that codes for the protein PRDX6. PRDX6 has shown to be
abundantly expressed in hepatocytes, implying that it counteracts circulating oxidants
[Wang et al. 2003]. As with Sod1 this over expression of Prdx6 represents an immune
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response to excessive ROS. The only gene that showed significant downregulation for
both treated groups was Ptgs2 (Figure 6). Ptgs2 expression is known to increase in the
presence of inflammatory stimuli [Hellman et al. 2015]. Thus, downregulation is not in
line with our anticipated findings. We would expect inflammation to be present and
triggering upregulation of the Ptgs2 in treated individuals. Further study of the histology
of hepatic tissue of 2AA treated groups could be carried out to assess the inflammation
response to oxidative stress.
IgA protein concentration was found to be statically insignificant in treated
groups as compared to the control (Figure 5) while AST activity was marginally
increased in treated groups (Figure 3). IgA is an antibody produced in immune responses.
Research has shown that the liver is very involved in the secretory IgA system, and liver
disease has been shown to alter IgA metabolism [Brown & Kloppel 1989]. For this
reason, we would have expected to see elevated IgA levels in the serum of treated
individuals, though we were not able to demonstrate this relationship in this study.
Elevated AST activity has been associated with liver damage in previous studies [Amin
& Hamza 2005]. In this study we were only able to demonstrate slight elevation of the
liver enzyme AST.
Conclusion and Future Direction
In conclusion some evidence of oxidative stress due to dietary exposure to 2AA
was demonstrated in this study, but further study is needed to conclusively determine this
effect. We were unable to conclusively demonstrate inflammation of hepatic tissues in
this study. Further study to analyze the histology of liver tissues could be incorporated
into future experiments to help demonstrate inflammation and damage to hepatic tissues.
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Another approach to help quantify liver damage could be to incorporate quantification of
serum alanine transaminase (ALT). ALT is a liver enzyme like AST that has been shown
to be a very specific marker of hepatocellular injury [Hall & Cash 2012]. Additionally,
body weight analysis could be performed in future animal study portions to help quantify
toxicity of 2AA. This could also be coupled with a higher dose regimented treatment
group to determine if toxicity was high enough to demonstrate adequate results in this
study. Total protein analysis could also be incorporated into future experimental designs
to quantify specific protein values as a relative concentration of the total protein
concentration. This could help determine if elevated values represent an elevation in one
specific protein or the total concentration as a whole.
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